Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xueying Gao
The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
One-Step Fabrication of Carbonaceous Solid Acid Derived From Lignosulfonate for the Synthesis of Biobased Furan Derivatives
RSC Advances
Chemistry
Chemical Engineering
Related publications
Ertugliflozin: A New SGLT2 Inhibitor for Type 2 Diabetes
Prescriber
Pharmacology
The Association Between KCNQ1 Gene Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis
PLoS ONE
Multidisciplinary
Association Between Cardiorespiratory Fitness and Risk of Type 2 Diabetes: A Meta-Analysis
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients With Type 2 Diabetes
Hormone and Metabolic Research
Biochemistry
Endocrinology
Clinical Biochemistry
Medicine
Metabolism
Diabetes
Combining SGLT2 Inhibitor and GLP-1 Agonist: Exaggerated Weight Loss in a Morbidly Obese Patient With Type 2 Diabetes
British Journal of Diabetes
Qtern: DPP-4 and SGLT2 Inhibitor Combination for Type 2 Diabetes
Prescriber
Pharmacology
DPP-4/SGLT2 Inhibitor Combined Therapy for Type 2 Diabetes
Prescriber
Pharmacology
Meta-Analysis of the Association Between Adiponectin SNP 45, SNP 276 and Type 2 Diabetes Mellitus
Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
Drugs in Context
Molecular Medicine
Pharmacology